Clinical Trial Update: Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing vasopressin injection to misoprostol for reducing blood loss and operation time during hysteroscopic myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submucous Leiomyoma of Uterus

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• vasopressin injection (vasopressin)

Snippet

Sponsor: Zagazig University | Conditions: Submucous Leiomyoma of Uterus | Phase 2, Phase 3 | Status: COMPLETED